- (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis Business Wire
- Vertex Pharmaceuticals’ cystic fibrosis therapy Alyftrek granted EC approval PMLiVE
- Hundreds of cystic fibrosis patients become eligible for ‘life-changing’ therapy the-independent.com